EFUNG CAPITAL
Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institutionโ 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VC Institutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the... most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.
EFUNG CAPITAL
Social Links:
Industry:
Finance Financial Services Venture Capital
Founded:
1996-01-01
Status:
Active
Contact:
0755-8831-6141
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Mobile Non Scaleable Content IPv6 ASP.NET IIS ASP.NET 4.0 IIS 8 China Telecom
Similar Organizations
CDH Investments
CDH Investments is an international alternative asset fund manager with more than $2.0 billion of committed capital under management.
Folius Ventures
Folius Ventures invests, popularizes, and participates in the construction of the Web3 ecosystem.
Gobi Partners
Gobi Partners is the most interconnected Pan-Asian venture capital firm across North Asia, South Asia, and ASEAN.
Current Employees Featured
Founder
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-05-27 | JSD | EFung Capital investment in Series A - JSD | N/A |
2022-03-29 | CellOrigin Biotech | EFung Capital investment in Venture Round - CellOrigin Biotech | 100 M CNY |
2022-01-13 | West Lake Omi | EFung Capital investment in Seed Round - West Lake Omi | N/A |
2022-01-05 | Atom Bioscience & Pharmaceutical | EFung Capital investment in Series C - Atom Bioscience & Pharmaceutical | 45 M USD |
2022-01-01 | Cloudbreak Therapeutics | EFung Capital investment in Series C - Cloudbreak Therapeutics | 130 M USD |
2021-12-31 | XuanZhu Pharma | EFung Capital investment in Series B - XuanZhu Pharma | 610.5 M CNY |
2021-12-27 | Kind Pharmaceutical | EFung Capital investment in Series B - Kind Pharmaceutical | 50 M USD |
2021-12-21 | BioInno | EFung Capital investment in Series A - BioInno | N/A |
2021-12-16 | CirCode | EFung Capital investment in Seed Round - CirCode | 20 M USD |
2021-11-16 | JGene Biotechnology | EFung Capital investment in Angel Round - JGene Biotechnology | N/A |